The Technology Development Board today penned an agreement with Bangalore based M/s TIEA Connectors Private Limited under the initiative “Commercialization of Indigenous Technologies through Tech Start-ups”. The Board has pledged a support of Rs. 3.81 crore out of the total project cost of Rs. 8.19 crore for the project “Commercialization of micro-electronic harsh environment connectors and terminals”. The start-up has graduated from the Indian Institute of Science, Bangalore incubator, the Society for Innovation and Development (SID-IISc).

The Technology Development Board (TDB), operating under the Department of Science & Technology (DST), is thrilled to announce its strategic partnership with M/s Chemlife Innovations Pvt. Ltd., headquartered in Bengaluru, Karnataka. This collaboration marks a significant stride in advancing the project titled "Commercialization and Manufacturing of Bio-Trace Minerals used in Feed for Animals," a visionary endeavour that harmonizes seamlessly with TDB's commitment to fostering impactful scientific innovation.

Prime Minister Shri Narendra Modi has aptly stated that "India's progress hinges on our ability to embrace technology and innovation." These words resound with the Government of India's dynamic initiatives in the field of wireless communication technology.

In a significant move to bolster the Micro, Small, and Medium Enterprise (MSME) sector in India, the Technology Development Board (TDB) and the Small Industries Development Bank of India (SIDBI) have formalized a Memorandum of Understanding (MoU) to facilitate easier access to credit for enterprises engaged in the development and commercial application of indigenous or imported technology.

In a significant stride towards fortifying indigenous manufacturing capabilities and fostering innovation in the pharmaceutical sector, the Technology Development Board (TDB) has entered into an agreement with M/s Alchem Synthon Pvt. Ltd., Mumbai. The board will provide a loan assistance of ₹8.6 crores out of the total project cost of ₹19.01 crores for the "Development and Commercialization of Advanced Pharmaceutical Intermediates, Fine & Specialty Chemicals."